Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home INVESTOR RELATIONS shareholder information

Shareholder Information

Financial Calendar

2010

 

Date type Event
25/02/2010 Results Full Year Results 2009
29/04/2010 Meeting Annual General Meeting
19/05/2010 Report Quarterly Report
26/08/2010 Results Half Year Results
18/11/2010 Report Quarterly Report

Closed periods: 25/01/2010 - 26/02/2010; 04/05/2010 - 20/05/2010;

                       12/08/2010 - 27/08/2010; 04/11/2010 - 19/11/2010

 

 

Shareholder Meetings

Annual General Meeting 2010

Extraordinary Shareholders Meeting - 30 October 2009

Annual General Meeting 2009

Extraordinary Shareholders Meeting - 23 January 2009

Annual General Meeting 2008

 

Special Report Board of Directors

Only available in Dutch

 

Articles of Association

 

IPO Prospectus

 

SPO Prospectus & placard

Info relating to the exercise of rights of shareholders and changes to the rights of shareholders

Not applicable

 

Annual information

Not applicable

 

 

Latest News


27/07/2010

ABLYNX ANNOUNCES CHANGE IN MANAGEMENT

23/07/2010

ABLYNX ANNOUNCES WARRANT EXERCISE

12/07/2010

NOVARTIS OBTAINS LICENSES TO DEVELOP AND COMMERCIALISE TWO NOVEL NANOBODIES®


Email alerts

If you would like to receive updates on the company news, please
click here